Natural Products as Modulators of ABC Transporters in Breast Cancer

Yoganishalini Sagadevan1, Reyhaneh Farghadani1,2, Ammu K Radhakrishnan1

  • 1Jeffrey Cheah School of Medicine and Health Sciences, Monash University Malaysia, Jalan Lagoon Selatan, Sunway City, Malaysia.

Insights

Natural products can overcome breast cancer multidrug resistance (MDR) by inhibiting ATP-binding cassette (ABC) transporters. These compounds enhance chemotherapy efficacy and reduce toxicity, offering new therapeutic strategies for aggressive breast cancer subtypes.

Area of Science:

  • Oncology
  • Pharmacology
  • Natural Product Chemistry

Background:

  • Breast cancer, especially triple-negative breast cancer (TNBC), faces treatment challenges due to multidrug resistance (MDR).
  • ATP-binding cassette (ABC) transporters (e.g., P-gp, BCRP, MRP1) are key drivers of MDR by actively exporting chemotherapeutic drugs.
  • This efflux reduces intracellular drug concentrations, leading to treatment failure and poor patient outcomes.

Purpose of the Study:

  • To review the potential of natural products in overcoming MDR in breast cancer by targeting ABC transporters.
  • To explore the mechanisms by which natural products modulate ABC transporter activity and related pathways.
  • To assess the synergistic effects of natural products with conventional chemotherapy in breast cancer treatment.

Main Methods:

  • A comprehensive literature search was performed across major scientific databases (Ovid Medline, PubMed, Scopus, Embase, Web of Science, EBSCOhost).
  • Articles were screened using a two-stage process (title/abstract and full text review), supplemented by reference list searches.
  • The review synthesized findings on natural product interactions with ABC transporters and MDR-related pathways.

Main Results:

  • Natural products inhibit ABC transporters via suppression of protein and mRNA expression, and direct inhibition of drug efflux.
  • These compounds modulate indirect regulatory pathways, including NF-κB, YB-1, PI3K/Akt signaling, and ATPase activity.
  • Natural products demonstrate synergistic effects with chemotherapeutics like doxorubicin and paclitaxel, enhancing drug efficacy and reducing toxicity.

Conclusions:

  • Natural products show significant promise as adjunct therapies to reverse MDR in breast cancer.
  • Targeting ABC transporters with natural compounds offers a novel strategy to improve treatment outcomes for resistant breast cancer.
  • Further research into these natural agents could lead to improved therapeutic regimens and better patient survival rates.

Related Concept Videos

ABC Transporters: Exporter01:31

ABC Transporters: Exporter

ATP-binding cassette or ABC transporter is the largest superfamily of integral membrane proteins. The transporters have transmembrane-binding domains (TMDs) and nucleotide-binding domains (NBDs). The TMDs are specific to their substrates, whereas the NBDs are similar to engines that complete ATP hydrolysis to complete the substrate transport. They can be full transporters consisting of two TMDs and NBDs, half transporters with one TMD and NBD, while some encoded with a single TMD or NBD are...
ABC Transporters: Importer01:27

ABC Transporters: Importer

ATP-binding cassette or ABC transporters are a class of ATP-driven pumps that hydrolyze ATP to move solutes across the membrane. They can be grouped into importers and exporters. While exporters are present in all domains of life, importers exist only in bacteria and some plants.
In bacteria, based on the number of transmembrane helices and the chemical nature of their substrates, the ABC importers can be divided into three types:
Carrier-Mediated Transport01:06

Carrier-Mediated Transport

Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters01:16

Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters

The pharmacogenetics of drug transporters is increasingly recognized as a critical factor influencing interindividual variability in drug absorption, distribution, and elimination. These membrane-bound proteins regulate drugs' movement across cellular barriers by actively pumping them out (efflux) or facilitating their uptake (influx). Among the major transporter families, ATP-binding cassette (ABC) and solute carrier (SLC) transporters play particularly prominent roles. Genetic polymorphisms...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Nonlinear Pharmacokinetics: Role of Transporters01:27

Nonlinear Pharmacokinetics: Role of Transporters

A drug's nonlinear kinetics can be influenced by a diverse range of transporter proteins that serve as crucial players in drug distribution. These transporters, found within cells, can enhance or reduce local drug concentrations by facilitating the influx or efflux of drugs. For instance, the expression of xenobiotic transporters can be influenced by factors such as age and gender, potentially impacting the linearity of drug response.
Polymorphisms occurring in drug transporters can alter...